Institutional investors hold a majority ownership of AMGN through the 82.53% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HANDELSBANKEN FONDER AB Bought 17.5 Thousand shares of Amgen
QS BATTERYMARCH FINANCIAL MANAGE... Bought 16.8 Thousand shares of Amgen
AMUNDI (UK) LTD. Bought 15.4 Thousand shares of Amgen